Armistice Capital, LLC Forma Therapeutics Holdings, Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $7.83 Million - $15.4 Million	1,536,000 Added 48.0%	4,736,000 $32.6 Million
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $11.2 Million - $19.7 Million	1,344,000 Added 72.41%	3,200,000 $29.8 Million
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $25.2 Million - $46.2 Million	1,856,000 New	1,856,000 $26.4 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.